PYPD — PolyPid Ltd.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1611842 ·
Last close
$5.31
Market Cap
$107.86M
52W High
$5.73
52W Low
$3.06
ADV30
105,387
Next earnings
2026-11-11

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -7,849,000 -7,849,000 15,234,000 6,563,000 9,846,000
Mar 2026 0 — -7,760,000 -7,728,000 19,160,000 8,888,000 10,380,000
Dec 2025 0 — -8,530,000 -8,473,000 22,307,000 6,402,000 11,334,000
Sep 2025 0 — -7,455,000 -7,451,000 26,841,000 9,669,000 11,476,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-309,228,000
Inventory
$1,106,000
Receivables
—
ST Investments
$2,021,000
EBIT TTM
$-33,471,000
Pretax Income TTM
$-33,635,000
Interest Exp TTM
$1,485,000
Analysts
4

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -32,967,000 -34,169,000 22,307,000 11,334,000 10,973,000 -27,879,000
Dec 2024 0 -28,029,000 -29,022,000 25,220,000 17,536,000 7,684,000 -21,963,000
Dec 2023 0 -22,867,000 -23,865,000 15,372,000 17,468,000 -2,096,000 -17,236,000
Dec 2022 0 -38,888,000 -39,557,000 25,971,000 20,142,000 5,829,000 -34,317,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.23

Max Pain — expiry 2027-02-19

max pain strike: $5.00 · spot: $5.31 · call oi: 1,828 · put oi: 279
Expected Move to 2027-02-19: ±$2.79 (52.45%) — implied range $2.52 – $8.09 · ATM straddle on $5.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
APYX Apyx Medical Corp $105.31M $2.50 —
VANI Vivani Medical, Inc. $112.75M $1.25 —
LAKE LAKELAND INDUSTRIES INC $101.99M $10.27 —
NTRB NutriBand Inc. $100.04M $8.23 —
ECOR electroCore, Inc. $99.45M $11.03 —

News headlines (Yahoo Finance, 1h cache)

PolyPid Announces Participation in Upcoming Fall Investor Conferences
2026-09-15 12:30 · Yahoo
PolyPid (PYPD) Q2 2026 Earnings Call Transcript
2026-08-19 15:27 · Yahoo
PolyPid Ltd (PYPD) (Q2 2026) Earnings Call Highlights: FDA Priority Review and $30M Azurity ...
2026-08-12 23:03 · Yahoo
PolyPid Ltd. Q2 2026 Earnings Call Summary
2026-08-12 21:07 · Yahoo
PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026
2026-07-30 12:00 · Yahoo
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
2026-07-29 12:30 · Yahoo
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
2026-07-21 13:15 · Yahoo
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
2026-07-21 11:30 · Yahoo
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
2026-06-01 12:30 · Yahoo
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
2026-05-20 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.